High-level tissue-specific expression of functional human factor VIII in mice

Human Gene Therapy

Volumn 7, Issue 2, 1996, Pages 183-195

  Connelly, Sheila ^a   Gardner, Joann M ^a   McClelland, Alan ^a   Kaleko, Michael ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING DISORDER; CELL STRAIN HEPG2; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSDUCTION; HEMOPHILIA A; INTRON; LIVER CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BLOOD LEVEL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANIMALIA;

EID: 0030069229     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.2-183     Document Type: Article

References (65)

1. BABISS, L.E., FRIEDMAN, J.M., and DARNELL, J.E., JR. (1986). Cellular promoters incorporated into the adenovirus genome: Effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Mol. Cell. Biol. 6, 3798-3806.
2. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
3. BI, L., LAWLER, A.M., ANTONARAKIS, S.E., HIGH, K.A., GERHART, J.D., and KAZAZIAN, H.H., JR. (1995). Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genet. 10, 119-121.
4. BRINKHOUS, K.M., SANDBERG, H., GARRIS, J.B., MATTSSON, C., PALM, M., GRIGGS, T., and READ, M.S. (1985). Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc. Natl. Acad. Sci. USA 82, 8752-8756.
5. BRINSTER, R.L., ALLEN, J.M., BEHRINGER, R.R., GELINAS, R.E., and PALMITER, R.D. (1988). Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA 85, 836-840.
6. BUCHMAN, A.R., and BERG, P. (1988). Comparison of intron-dependent and intron-independent gene expression. Mol. Cell Biol. 8, 4395-4405.
7. CHOI, T., HUANG, M., GORMAN, C., and JAENISCH, R. (1991). A generic intron increases gene expression in transgenic mice. Mol. Cell Biol. 11, 3070-3074.
8. CHOO, K.H., RAPHAEL, K., McADAM, W., and PETERSON, M.G. (1987). Expression of active human blood clotting factor IX in transgenic mice: Use of a cDNA with complete mRNA sequence. Nucleic Acids Res. 15, 871-884.
9. CONNELLY, S., SMITH, T.A.G., DHIR, G., GARDNER, J.M., MEHAFFEY, M.G., ZARET, K.S., McCLELLAND, A., and KALEKO, M. (1995). In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6, 185-193.
10. DIPERSIO, C.M., JACKSON, D.A., and ZARET, K.S. (1991). The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol. Cell. Biol. 11, 4405-4414.
11. DORNER, A.J., and KAUFMAN, R.J. (1994). The levels of endoplasmic reticulum proteins and ATP affect folding and secretion of selective proteins. Biologicals 22, 103-112.
12. DORNER, A.J., WASLEY, L.C., and KAUFMAN, R.J. (1992). Overexpression of GRP78 mitigates stress induction of glucose regulated proteins and blocks secretion of selective proteins in Chinese hamster ovary cells. EMBO J. 11, 1563-1571.
13. DREYFUSS, G., SWANSON, M.S., and PINOL-ROMA, S. (1988). Heterogenous nuclear ribonucleoprotein particles and the pathway of mRNA formation. Trends Biochem. Sci. 13, 86-91.
14. DWARKI, V.J., BELLONI, P., NIJJAR, T., SMITH, J., COUTO, L., RABIER, M., CLIFT, S., BERNS, A., and COHEN, L.K. (1995). Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl. Acad. Sci. USA 92, 1023-1027.
15. EATON, D.L., WOOD, W.I., EATON, D., HASS, P.E., HOLLINGSHEAD, P., WION, K., MATHER, J., LAWN, R.M., VEHAR, G.A., and GORMAN, C. (1986). Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 25, 1-2.
16. FRIEDMAN, J.M., BABISS, L.E., CLAYTON, D.F., and DARNELL, J.E., JR. (1986). Cellular promoters incorporated into the adenovirus genome: Cell specificity of albumin and immunoglobulin expression. Mol. Cell. Biol. 6, 3791-3797.
17. GILES, A.R., TINLIN, S., and GREENWOOD, R. (1982). A canine model of hemophilic (factor VIII:C deficiency) bleeding. Blood 60, 727-731.
18. GORSKI, K., CARNEIRO, M., and SHIBLER, U. (1986). Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47, 767-776.
19. HAFENRICHTER, D.G., WU, X., RETTINGER, S.D., KENNEDY, S.C., FLYE, M.W., and PONDER, K.P. (1994). Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 10, 3394-3404.
20. maj globin gene. Cell 17, 737-747.
21. HAYASHI, Y., DEPAOLI, A.M., BURANT, C.F., and REFETOFF, S. (1994). Expression of a thyroid hormone-responsive recombinant gene introduced into adult mice livers by replication-defective adenovirus can be regulated by endogenous thyroid hormone receptor. J. Biol. Chem. 269, 23872-23875.
22. HOEBEN, R.C., VAN DER JAGT, R.C., SCHOUTE, F., VAN TILBURG, N.H., VERBEET, M.P., BRIET, E., VAN ORMONDT, H., and VAN DER EB, A.J. (1990). Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer. J. Biol. Chem. 265, 7318-7323.
23. HOEBEN, R.C., EINERHAND, M.P., BRIET, E., VAN ORMONDT, H., VALERIO, D., and VAN DER EB, A.J. (1992). Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells. Thromb. Haemost. 67, 341-345.
24. HOEBEN, R.C., FALLAUX, F.J., VAN TILBURG, N.H., CRAMER, S.J., VAN ORMONDT, H., BRIET, E., and VAN DER EB, A.J. (1993). Toward gene therapy for hemophilia A: Long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice. Hum. Gene Ther. 4, 179-186.
25. HOEBEN, R.C., FALLAUX, F.J., CRAMER, S.J., VAN DEN WOLLENBERG, J.M., VAN ORMONDT, H., BRIET, E., and VAN DER EB, A.J. (1995). Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region. Blood 85, 2447-2454.
26. HOYER, L.W., WYSHOCK, E., and COLEMAN, R.W. (1994). Coagulation cofactors V and VIII. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, Third Edition. R.W. Colman, J. Hirsch, V.J. Marder, and E.W. Salzman, eds. (J.B. Lippincott Company, Philadelphia) pp. 109-133.
27. HUANG, M.T.F., and GORMAN, C.M. (1990). Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18, 937-947.
28. ISHIBASHI, S., BROWN, M.S., GOLDSTEIN, J.L., GERARD, R.D., HAMMER, E.R., and HERZ, J. (1993). Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893.
29. ISRAEL, D.I., and KAUFMAN, R.J. (1990). Retroviral-mediated transfer and amplification of a functional human factor VIII gene. Blood 75, 1074-1080.
30. JALLAT, S., PERRAUND, F., DALEMANS, W., BALLAND, A., DIETERIE, A., FAURE, T., MEULIEN, P., and PAVIRANI, A. (1990). Characterization of recombinant human Factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J. 9, 3295-3301.
31. KAUFMAN, R.J., WASLEY, L.C., DAVIES, M.V., WISE, R.J., ISRAEL, D.I., and DORNER, A.J. (1989). Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol. Cell. Biol. 9, 1233-1242.
32. KAUFMAN, R.J. (1992). Biological regulation of factor VIII activity. Annu. Rev. Med. 43, 325-339.
33. KAUFMAN, R.J., WASLEY, L.C., and DORNER, A.J. (1988). Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263, 6352-6362.
34. KAY, M.A., LANDEN, C.N., ROTHENBERG, S.R., TAYLOR, L.A., LELAND, F., WIEHLE, S., FANG, B., BELLINGER, D., FINEGOLD, M., THOMPSON, A.R., READ, M., BRINKHOUS, K.M., and WOO, S.L. (1994). In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91, 2353-2357.
35. KOEBERL, D.D., HALBERT, C.L., KRUMM, A., and MILLER, A.D. (1995). Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Hum. Gene Ther. 6, 469-479.
36. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
37. KURACHI, S., HITOMI, Y., FURUKAWA, M., and KURACHI, K. (1995). Role of intron I in expression of the human factor IX gene. J. Biol. Chem. 270, 5276-5281.
38. LIU, J.-K., BERGMAN, Y., and ZARET, K.S. (1988). The mouse albumin promoter and a distal upstream site are simultaneously DNase I hypersensitive in liver chromatin and bind similar liver-abundant factors in vitro. Genes & Dev. 2, 528-541.
39. LIU, J.-K., DIPERSIO, C.M., and ZARET, K.S. (1991). Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol. Cell. Biol. 11, 773-784.
40. LOZIER, J.N., and BRINKHOUS, K.M. (1994). Gene therapy and the hemophilias. J. Am. Med. Assn. 271, 47-51.
41. LYNCH, C.M., ISRAEL, D.I., KAUFMAN, R.J., and MILLER, A.D. (1993). Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum. Gene Ther. 4, 259-272.
42. MARIANI, G., GHIRARDINI, A., and BELLOCCO, R. (1994). Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommitte. Thromb. Haemost. 72, 155-158.
43. PALMITER, R.D., SANGREN, E.P., AVARBOCK, M.R., ALLEN, D.D., and BRINSTER, R.L. (1991). Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. USA 88, 478-482.
44. PINKERT, C.A., ORNITZ, D.M., BRINSTER, R.L., and PALMITER, R.D. (1987). An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes & Dev. 1, 268-276.
45. PITTMAN, D.D., and KAUFMAN, R.J. (1993). Site directed mutagenesis and expression of coagulation factors VIII and V in mammalian cells. Methods Enzymol. 222, 236-260.
46. PITTMAN, D.D., ALDERMAN, E.M., TOMKINSON, K.N., WANG, J.H., GILES, A.R., and KAUFMAN, R.J. (1993). Biochemical, Immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81, 2925-2935.
47. POWELL, D.J., FRIEDMAN, J.M., OULETTE, A.J., KRAUTER, K.S., and DARNELL, J.E., JR. (1984). Transcriptional and posttranscriptional control of specific messenger RNAs in adult and embryonic liver. J. Mol. Biol. 179, 21-35.
48. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BRIAND, P., KAPLAN, J-C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
49. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECODQ, J-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
50. SCHEIBEL, E., INGERSLEV, J., DALSGAARD-NIELSEN, J., STENBJERG, S., and KNUDSEN, J.B. (1987). Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated. Thromb. Haemost. 58, 1049-1052.
51. SMITH, T.A.G., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., McCLELLAND, A., and KALEKO, M. (1993). Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5, 397-402.
52. STRATFORD-PERRICAUDET, L.D., LEVRERO, M., CHASSE, J., PERRICAUDET, M., and BRIAND, P. (1990). Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1, 241-256.
53. STRATFORD-PERRICAUDET, L.D., and PERRICAUDET, M. (1994). Gene therapy: The advent of adenovirus. In Gene therapeutics: Methods and Applications of Direct Gene Transfer. J.A. Wolff, ed. (Birkhauser, Boston) pp. 344-362.
54. SWANSON, M.E., HUGHES, T.E., ST. DENNY, I., FRANCE, D.S., PATERNITI, J.R., TAPPARELLI, C., GFELLER, P., and BURKI, K. (1992). High level expression of human apolipoprotein A-1 in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-1. Transgenic Res. 1, 142-147.
55. THIMMAPPAYA, B., WEINBERGER, C., SCHNEIDER, R.J., and SHENK, T. (1982). Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 3, 543-551.
56. TOLSTOSHEV, P., MITTEREDER, N., YEI, S., and TRAPNELL, B.C. (1994). Adenovirus vectors for gene therapy. In Cancer Chemotherapy: Challenges for the Future. (Excerpta Medica, Ltd, Tokyo) pp. 23-31.
57. TOOLE, J.J., KNOPF, J.L., WOZNEY, J.M., SULTZMAN, P.A., BUECKER, J., PITTMAN, D.D., KAUFMAN, R.J., BROWN, E., SHOEMAKER, C., ORR, E.C., AMPHLETT, G.W., FOSTER, W.B., COE, M.L., KNUTSON, G.J., FASS, D.N., and HEWICK, R.M. (1984). Molecular cloning of a cDNA encoding antihemophiliac factor. Nature 312, 342-346.
58. TOOLE, J.J., PITTMAN, D.D., ORR, E.C., MURTHA, P., WASLEY, L.C., and KAUFMAN, R.J. (1986). A large region (≈95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc. Natl. Acad. Sci. USA 83, 5939-5942.
59. VEHAR, G.A., LAWN, R.M., TUDDENHAM, E.G.D., and WOOD, W.I. (1991). Factor VIII and factor V: Biochemistry and pathophysiology. In Biotechnology of plasma proteins. Curr. Stud. Hematol. Blood. Transf. A. Albertini, C.L. Lenfant, P.M. Mannucci, and J.J. Sixmaeds, eds. (Karger, Base) pp. 2155-2170.
60. WOOD, W.I., CAPON, D.J., SIMONSEN, C.C., EATON, D.L., GITSCHIER, J., KEYT, B., SEEBURG, P.H., SMITH, D.H., HOLLINGSHEAD, P., WION, K.L., DELWART, E., TUDDENHAM, E.G.D., VEHAR, G.A., and LAWN, R.M. (1984). Expression of active human factor VIII from recombinant DNA cloned. Nature 312, 330-337.
61. YANG, Y., RAPER, S.E., COHN, J.A., ENGELHARDT, J.F., and WILSON, J.M. (1993). An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90, 4601-4605.
62. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
63. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
64. ZARET, K.S., DIPERSIO, C.M., JACKSON, D.A., MONTIGNY, W.J., and WEINSTAT, D.L. (1988). Conditional enhancement of liver-specific gene transcription. Proc. Natl. Acad. Sci. USA 85, 9076-9080.
65. ZATLOUKAL, K., COTTEN, M., BERGER, M., SCHMIDT, W., WAGNER, E., and BIRNSTIEL, M.L. (1994). In vivo production of human factor VIII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Proc. Natl. Acad. Sci. USA 91, 5148-5152.